Published in Psychopharmacology (Berl) on July 29, 2004
Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash. Psychopharmacology (Berl) (2013) 0.76
Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30
Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res (2001) 2.98
A review of 25 years of the social interaction test. Eur J Pharmacol (2003) 2.74
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav (1986) 2.73
Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther (2000) 2.26
Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav (1991) 2.04
Aggressive behavioral phenotypes in mice. Behav Brain Res (2001) 1.80
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl) (2002) 1.73
Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther (1999) 1.67
Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend (2002) 1.65
Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol (2003) 1.61
An assessment of the long-term developmental and behavioral teratogenicity of prenatal nicotine exposure. Behav Brain Res (2004) 1.56
The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl) (2000) 1.52
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) (2003) 1.49
Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol (1998) 1.35
Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl) (2003) 1.30
Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) (2002) 1.30
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2003) 1.30
Review of bupropion for smoking cessation. Drug Alcohol Rev (2003) 1.23
[The exploration reaction in the mouse. Preliminary note]. Therapie (1963) 1.21
Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res (2000) 1.20
Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl) (2003) 1.19
Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev (1998) 1.17
Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav (2004) 1.17
Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res (2003) 1.13
Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine. J Pharmacol Exp Ther (2002) 1.13
Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol Behav (1993) 1.12
Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm Behav (2003) 1.06
Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther (1980) 1.02
Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol (2003) 1.00
Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology (Berl) (2002) 0.98
Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology (Berl) (2001) 0.97
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology (2002) 0.97
Serial analysis of gene expression predicts structural differences in hippocampus of long attack latency and short attack latency mice. Eur J Neurosci (2003) 0.96
Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs (2003) 0.95
Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol (2002) 0.94
Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur Neuropsychopharmacol (1998) 0.89
GABA(A) but not GABA(B) receptor stimulation induces antianxiety profile in rats. Pharmacol Biochem Behav (2001) 0.87
Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res (1997) 0.87
Anorectic and behavioural effects of bupropion. Gen Pharmacol (1988) 0.86
Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze. Behav Brain Res (2000) 0.86
Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.83
Behavioral stress response of genetically selected aggressive and nonaggressive wild house mice in the shock-probe/defensive burying test. Pharmacol Biochem Behav (1996) 0.83
Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol (2000) 0.82
Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav Brain Res (1997) 0.82
Reduced isolation-induced aggressiveness in mice following NAALADase inhibition. Psychopharmacology (Berl) (2003) 0.80
Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test. Psychopharmacology (Berl) (2000) 0.80
Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration. Behav Brain Res (2003) 0.80
Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett (2003) 0.79
Bupropion induces sniffing: a possible dopaminergic mechanism. Eur Neuropsychopharmacol (1996) 0.77
Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats. Behav Pharmacol (2002) 0.77
Effects of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats. Pharmacol Biochem Behav (1997) 0.77
Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology (1991) 0.76
Must antidepressants be anticholinergic to inhibit muricide? Pharmacol Biochem Behav (1986) 0.76
Central effects of repeated treatment with bupropion. Pol J Pharmacol Pharm (1986) 0.76
The effect of the type of opponent in tests of murine aggression. Behav Processes (1981) 0.76
Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat. Pharmacol Biochem Behav (1990) 0.76
Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models. J Pharmacol Exp Ther (1987) 0.75
[An unusual case of tricuspid endocarditis by Enterococcus faecalis in native valve]. Med Clin (Barc) (2003) 1.39
Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology (2007) 1.04
Online hourly determination of 62 VOCs in ambient air: system evaluation and comparison with another two analytical techniques. J Air Waste Manag Assoc (2002) 0.98
Concurrent exposure to perfluorooctane sulfonate and restraint stress during pregnancy in mice: effects on postnatal development and behavior of the offspring. Toxicol Sci (2007) 0.93
Influence of maternal restraint stress on the long-lasting effects induced by prenatal exposure to perfluorooctane sulfonate (PFOS) in mice. Toxicol Lett (2007) 0.90
Interactions in developmental toxicology: concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol Lett (2005) 0.88
Individual differences in novelty-seeking and behavioral responses to nicotine: a review of animal studies. Curr Drug Abuse Rev (2009) 0.86
Local origin and activity-dependent generation of nestin-expressing protoplasmic astrocytes in CA1. Brain Struct Funct (2007) 0.83
Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.81
Neuroprotective effects of behavioural training and nicotine on age-related deficits in spatial learning. Behav Pharmacol (2006) 0.79
Effects of early training and nicotine treatment on the performance of male NMRI mice in the water maze. Neural Plast (2003) 0.78
Recognition memory and β-amyloid plaques in adult Tg2576 mice are not modified after oral exposure to aluminum. Alzheimer Dis Assoc Disord (2012) 0.77
Simultaneous cell death and upregulation of poly(ADP-ribose) polymerase-1 expression in early postnatal mouse retina. Invest Ophthalmol Vis Sci (2011) 0.76
Aluminum, restraint stress and aging: behavioral effects in rats after 1 and 2 years of aluminum exposure. Toxicology (2005) 0.76
A specific anti-aggressive effect of repeatedly administered lobeline. Addict Biol (2002) 0.76
Concurrent exposure to aluminum and stress during pregnancy in rats: Effects on postnatal development and behavior of the offspring. Neurotoxicol Teratol (2005) 0.76
Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.76
A new dicyemid from Octopus hubbsorum (Mollusca:Cephalopoda:Octopoda). J Parasitol (2010) 0.75